Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. clinical hematology
Show results for
Products
Services

Companies

News
Articles
Videos

Refine by
Date

  • Older

Clinical Hematology Articles & Analysis

12 news found

Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks

Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks

About Advanced Instruments Advanced Instruments is a global provider of scientific and analytical instruments for the bioprocessing, clinical and food and beverage industries. The company’s innovations have helped organizations improve quality of results, achieve reliable outcomes, and increase workplace productivity for more than 65 years. ...

ByAdvanced Instruments


Affimed Establishes Scientific Advisory Board

Affimed Establishes Scientific Advisory Board

(Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today the establishment of a Scientific Advisory Board (SAB) of renowned experts in their respective fields to provide scientific and clinical guidance on the development ...

ByAffimed GmbH


BioXcel Therapeutics Announces Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology

BioXcel Therapeutics Announces Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology

OnkosXcel, a Company subsidiary, to utilize proprietary AI-powered platform to progress therapies to address difficult-to-treat cancers with high unmet need New structure to unlock growth opportunities and maximize value of neuroscience and immuno-oncology franchises Lead pipeline asset, BXCL701, has shown clinical proof-of-concept in aggressive forms of prostate cancer and ...

ByBioXcel Therapeutics, Inc.


Amerigo Scientific Introduces the Launch of Polystreptavidin 350

Amerigo Scientific Introduces the Launch of Polystreptavidin 350

From rapid treatment and combating antimicrobial resistance, to providing personalized medicine, the need for clinical diagnostics, especially in vitro diagnostics, continues to expand. ...

ByAmerigo Scientific


Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B

The TRANSCEND program is a broad clinical program evaluating Breyanzi in multiple hematologic indications and treatment lines. ...

ByBristol Myers Squibb Corporate


First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)

First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)

Study explores opportunity to shift from clinic to home instillation of this promising non-surgical treatment Potential to transform care and access to treatment for this growing patient population UroGen Pharma Ltd. ...

ByUroGen Pharma, Inc.


Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society

Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society

Data from IND-enabling studies show accurate delivery, targeted biodistribution, favorable safety profile, durable suppression of seizures and reduction in disease pathology A first-in-human Phase 1/2 clinical trial of NRTX-1001 in people with drug-resistant mesial temporal lobe epilepsy has been initiated and will begin recruiting soon Neurona Therapeutics, a ...

ByNeurona Therapeutics


Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology

Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology

The latest call for proposals aims to provide funding for clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. The Oncomine Clinical Research Grant awards independent clinical research proposals with up to $200,000 in reagents and general funding. ...

ByThermo Fisher Scientific


Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary diseases and conditions, today announced the appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development. ...

ByLung Therapeutics, Inc.


Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System

Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System

In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Novel Securement Device Making Inroads

Novel Securement Device Making Inroads

This opportunity may become a reality for Adhezion Biomedical as SecurePortIV has been the subject of numerous clinical trials demonstrating clinical benefit and cost effectiveness, with several having results presented at the recent AVA meeting. The oncology/hematology department at the Mayo Clinic Arizona found securement and ...

ByAdhezion Biomedical, LLC


HORIBA Medical and NOEMALIFE signed a Worldwide Distribution Agreement for a dedicated version of the HALIA middleware

HORIBA Medical and NOEMALIFE signed a Worldwide Distribution Agreement for a dedicated version of the HALIA middleware

It is compatible with all our instruments range (Hematology, Clinical chemistry, Peri-analytical … all disciplines) and is also able to communicate with competitors’ instruments (all disciplines too) and Laboratory Information Systems. ...

ByHORIBA Europe GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT